Skip to content

Pentagastrin

VARIOUS

Also known as: ICI 50123, pentavlon, peptavlon

OfmFDA approvedATC V04CG04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Pentagastrin is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1974. DrugCentral lists 4 molecular targets, including Cckbr, Cckbr and CCKBR.

  • Approval status: ofm (first approved 1974 by the FDA).
  • Molecular targets: Cckbr, Cckbr, CCKBR and Cckar (4 listed in DrugCentral).
  • ATC code: V04CG04 (Tests for gastric secretion).
  • Molecular formula: C37H49N7O9S; molecular weight 767.90 g/mol.

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Gastrin/cholecystokinin type B receptorCckbrunknownIC50 9.10
Gastrin/cholecystokinin type B receptorCckbrunknownIC50 8.17
Gastrin/cholecystokinin type B receptorCCKBRunknownKi 7.84
Cholecystokinin receptor type ACckarunknownIC50 6.22

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1974-07-26FDA——

ATC classification

ATC codeTherapeutic hierarchy
V04CG04VARIOUS › DIAGNOSTIC AGENTS › OTHER DIAGNOSTIC AGENTS › Tests for gastric secretion

Chemical structure

Molecular formulaC37H49N7O9S
Molecular weight767.90 g/mol
CAS number5534-95-2
InChIKeyNEYNJQRKHLUJRU-DZUOILHNSA-N
PubChem CID9853654
CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Pentagastrin work?

Its molecular targets in DrugCentral include Cckbr, Cckbr, CCKBR and Cckar.

When was Pentagastrin first approved?

Pentagastrin was first approved by the FDA in 1974.

What is the chemical formula of Pentagastrin?

Pentagastrin has the molecular formula C37H49N7O9S and a molecular weight of 767.90 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1974-07-26
AgencyFDA
Targets4
Indications0
FormulaC37H49N7O9S
DrugCentral ID2088
Interactive profile